The pharmaceutical firm has committed a "significant" amount to the latest fund to be raised by investment firm LSP as part of a strategic collaboration agreement.

The weight-loss device developer, which has previously secured funding from Allergan and Boston Scientific, has now raised almost $80m altogether.

ObsEva, which is developing treatments for pregnancy-related conditions, received the funding from investors including pharmaceutical companies Merck Serono and Novo.

Queensland University and University College London team on tackling epilepsy.

Florida Biologix launches out of Florida University with backing from Ampersand.

Drug discovery startup TwoXar secures $3.4m in round backed by Stanford-StartX Fund.

Cell counting startup Ovizio Imaging Systems secures $9.1m in round including university investment consortium Qbic.

The fund is set to target Israel-based biotech startups and, according to Globes, plans to raise between $50m and $100m.